PaulRWalkerMDFACP

PubMed

• Immunotherapy: remember the host.
  Walker, P.> ;Translational Lung Cancer Research. 2023 Dec 26
• Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds.
  Paul R Walker> ;Journal of Thoracic Disease. 2023 Jul 31
• 2 citations
  Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy.
  Christine Son, Melissa Y Y Moey, Paul R Walker, Abdul R Naqash, Matthew Sean Peach, Andrew W Ju> ;Frontiers in Oncology. 2022 Jan 1
• 1 citations
  Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and...
  Mona A Marie, Zahra S Hamedi, Abdul Rafeh Naqash, Alexander Hoffman, Druid Atwell, Suneetha Amara, Mahvish Muzaffar, Paul R Walker, Li V Yang, Justin D McCallen> ;Frontiers in Oncology. 2022 Jan 1
• 11 citations
  Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After.
  Susan Woody, Aparna Hegde, Hyder Arastu, M Sean Peach, Nitika Sharma, Paul Walker, Andrew W Ju> ;Frontiers in Oncology. 2022 Jan 1
• Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy.
  C. Son, Melissa Y.Y. Moey, Abdul Rafeh Naqash, Paul R. Walker, M.S. Peach, A.W. Ju> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
• 11 citations
  Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
  Patricia Rich, R. Brian Mitchell, Eric Scott Schaefer, Paul R. Walker, J. Dubay, Jason Keith Boyd, D. Oubre, Ray D. Page, Mazen Khalil, Suman Sinha, Scott Boniol, Hafe...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 4 citations
  Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report.
  Abdul Rafeh Naqash, Mona A. Marie, Druid C Atwell, Mahvish Muzaffar, Nitika Sharma, Suneetha Amara, Darla K. Liles, Paul R. Walker, Li V. Yang> ;Acta Oncologica. 2021 May 3
• 211 citations
  Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.
  Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash, Patrick M. Forde, Josephine Feliciano, Kristen A. Marrone, David S. Ettinger, Christine L. Hann, Julie R. Brahmer, B...> ;JAMA Oncology. 2020 Dec 1
• 13 citations
  Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.
  Biagio Ricciuti, Abdul Rafeh Naqash, Jarushka Naidoo, Kartik Sehgal, Adam Miller, Kenneth L. Kehl, Deepti Venkatraman, Jacob Sands, Giuseppe Lamberti, Gonzalo Recondo,...> ;JTO Clinical and Research Reports. 2020 Nov 1
• 21 citations
  Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting.
  Melissa Y.Y. Moey, Anna N. Tomdio, Lauren Vaughan, Kevin O'Brien, Abdul Rafeh Naqash, Cynthia R. Cherry, Paul R. Walker, Blase A. Carabello, Justin D. McCallen> ;JACC. Cardiooncology. 2020 Sep 1
• Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis fr...
  Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, Vaia Florou, Yukihiro Toi, Cynthia Cherry, Maida Hafiz, Andrea De Giglio, Mavish Muzaffar, Sandip H Patel, Shunichi...> ;Cancer Immunology, Immunotherapy. 2020 Jul 1
• 27 citations
  Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global coh...
  Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, Vaia Florou, Yukihiro Toi, Cynthia Cherry, Maida Hafiz, Andrea De Giglio, Mavish Muzaffar, Sandip H Patel, Shunichi...> ;Cancer Immunology, Immunotherapy. 2020 Jul 1
• 12 citations
  Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
  Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Hub...> ;Clinical Lung Cancer. 2021 May 1
• 6 citations
  Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB).
  Hayley Stowe, Stella Ogake, Sunil Sharma, Suzanne Kelly, Morgan McDonald, Kayla Stanley, Paul R. Walker, Hyder Husain Arastu, Carlos Anciano Granadillo, Mark R. Bowlin...> ;Radiation Oncology. 2019 Jul 11
• 25 citations
  Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
  Abdul Rafeh Naqash, Ebenezer Ofori Appah, Li V. Yang, Mahvish Muzaffar, Mona A. Marie, Justin D. McCallen, Shravanti Macherla, Darla K. Liles, Paul R. Walker> ;Journal for Immunotherapy of Cancer. 2019 Jul 5
• 198 citations
  Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
  Chipman Rg Stroud, Aparna Madhukeshwar Hegde, Cynthia R. Cherry, Abdul Rafeh Naqash, Nitika Sharma, Srikala Addepalli, Sulochana Devi Cherukuri, Teresa Parent, Jessica...> ;Journal of Oncology Pharmacy Practice. 2019 Apr 1
• 2 citations
  A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome.
  Maida Hafiz, Suneha Sundaram, Abdul Rafeh Naqash, James Speicher, Ann Sutton, Paul R. Walker, Nizar Talaat> ;ACG Case Reports Journal. 2019 Mar 8
• 47 citations
  A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers.
  Samuel Cykert, Eugenia Eng, Paul R. Walker, M. Manning, Linda Robertson, Rohan Arya, Nora S. Jones, Dwight E. Heron> ;Cancer Medicine. 2019 Mar 1
• 1 citations
  Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR.
  Mark Bowling, Hyder Arastu, Victoria Edwards, Leisa Jackson, Scott Thurston, Jordan Reese, Hestia Mellert, Gary Pestano, Paul Walker> ;Cancer Drug Resistance. 2019 Jan 1
• Stage III non-small cell lung cancer: escalation matters, but how?
  Aparna Madhukeshwar Hegde, Paul R. Walker> ;Translational Lung Cancer Research. 2018 Apr 1
• 14 citations
  Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy.
  Cory Pierson, Taras Grinchak, Casey Sokolovic, Brandi Holland, Teresa Parent, Mark R. Bowling, Hyder Husain Arastu, Paul Walker, Andrew Ju> ;Radiation Oncology. 2018 Feb 27
• 14 citations
  Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms.
  Noah S. Kalman, Elisabeth Weiss, Paul R. Walker, Julian G. Rosenman> ;Clinical Lung Cancer. 2018 Jan 1
• 32 citations
  Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell deat...
  Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Butt, Grace K. Dy, Aparna Madhukeshwar Hegde, Mahvish Muzaffar, Li V. Yang, Maida Hafiz, Cynthia R. Cherry...> ;Acta Oncologica. 2017 Dec 15
• 38 citations
  The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer.
  Tithi Biswas, Jimmy T. Efird, Shreya Prasad, Charulata Jindal, Paul R. Walker> ;Oncotarget. 2017 Nov 20
• Join now to see all